Pharmaceutical Qib 209216-23-9 Entecavir Monohydrate Rau Kev Kho Mob Kab Mob Siab B
Khoomnpe | Entecavir monohydrate |
Synonyms | 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-ib monohydrate |
CAS Nr. | 209216-23-9 |
Qhov tshwm sim | Dawb mus rau dawb hmoov |
Molecular Formula | C12H15N5O3.H2O |
Molecular Luj | 295.30 Nws |
Kev siv | Pharmaceutical Qib lossis Kev Tshawb Fawb Lub Hom Phiaj |
Ntim | Raws li koj qhov kev thov |
Cia | Khaws nyob rau hauv nruj, lub teeb-resistant ntim nyob rau hauv ib qhov chaw txias |
Entecavir monohydrate CAS: 209216-23-9 | ||
Cov khoom | Txuj | Cov txiaj ntsig |
Qhov tshwm sim | Dawb mus rau dawb hmoov | Ua raws |
Optical kev sib hloov | +24.0°—+28.0°(DMF:MeOH=1:1 c=1%) | + 27.0 ° C |
Kev txheeb xyuas | A: Los ntawm IR, kom phim nrog cov qauv ua haujlwm | Ua raws |
B: Los ntawm HPLC, khaws lub sijhawm yuav tsum ua raws li tus qauv ua haujlwm | Ua raws | |
Dej | 5.8% -6.5% | 6.1% |
Isomer | Ib leeg ≤0.1% | 0.02% |
Tag nrho ≤0.5% | 0.02% | |
Yam khoom muaj feem | Ib qho impurity ≤0.1% | 0.05% |
Tag nrho impurities ≤0.3% | 0.07% | |
Residue ntawm ignition | ≤0.1% | 0.04% |
Cov hlau hnyav | £ 10 ppm | Ua raws |
Cov kuab tshuaj residual | Yuav tsum ua kom haum nrog tus qauv | Ua raws |
Assay | ≥99.8% | 99.9% |
Xaus:Ua raws li cov qauv hauv tsev. |
Cov ntaub ntawv tuam txhab
√ Kev tswj cov txheej txheem tag nrho hauv lub Hoobkas thiab cov kws tshaj lij cov neeg ua haujlwm; √ Zoo yog ib txwm peb xav txog sab saum toj, nruj QC system; √ 11 xyoo dhau los ntawm pab pawg muag khoom; √ Kev ywj pheej R & D lab; √ Ob qhov kev kos npe mus sij hawm ntev GMP kev cob qhia; √ Cov peev txheej nplua nuj ntawm ntau lub chaw ua haujlwm tsis ua haujlwm rau qhov project customized; √ Pab neeg ua haujlwm siab ua haujlwm nrog txoj hauv kev zoo ib yam.Sau koj cov lus ntawm no thiab xa tuaj rau peb